Newsletter: Vol 8, No. 1, March 2024

In this issue, read about published studies evaluating screening for medication abortion eligibility using an online programmed questionnaire and a new way to capture patient experience during childbirth as well as about our latest telemedicine medication abortion study, this time assessing use of a misoprostol-only regimen. Also read about an amicus brief filed in the U.S. Supreme Court on behalf of reproductive health researchers.

Read the full Newsletter